OSE Immunotherapeutics Statistics

Total Valuation

EPA:OSE has a market cap or net worth of EUR 157.05 million. The enterprise value is 125.19 million.

Market Cap	157.05M
Enterprise Value	125.19M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

EPA:OSE has 21.87 million shares outstanding. The number of shares has increased by 22.97% in one year.

Current Share Class	n/a
Shares Outstanding	21.87M
Shares Change (YoY)	+22.97%
Shares Change (QoQ)	+22.87%
Owned by Insiders (%)	21.19%
Owned by Institutions (%)	1.00%
Float	16.45M

Valuation Ratios

The trailing PE ratio is 3.56 and the forward PE ratio is 2.51.

PE Ratio	3.56
Forward PE	2.51
PS Ratio	1.82
PB Ratio	1.92
P/TBV Ratio	1.93
P/FCF Ratio	2.69
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.33, with an EV/FCF ratio of 2.15.

EV / Earnings	2.72
EV / Sales	1.50
EV / EBITDA	2.33
EV / EBIT	2.33
EV / FCF	2.15

Financial Position

The company has a current ratio of 4.93, with a Debt / Equity ratio of 0.54.

Current Ratio	4.93
Quick Ratio	4.70
Debt / Equity	0.54
Debt / EBITDA	0.82
Debt / FCF	0.75
Interest Coverage	18.48

Financial Efficiency

Return on equity (ROE) is 88.54% and return on invested capital (ROIC) is 35.12%.

Return on Equity (ROE)	88.54%
Return on Assets (ROA)	30.41%
Return on Invested Capital (ROIC)	35.12%
Return on Capital Employed (ROCE)	43.58%
Revenue Per Employee	1.60M
Profits Per Employee	885,231
Employee Count	55
Asset Turnover	0.75
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +108.12% in the last 52 weeks. The beta is 0.83, so EPA:OSE's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	+108.12%
50-Day Moving Average	6.92
200-Day Moving Average	7.63
Relative Strength Index (RSI)	57.36
Average Volume (20 Days)	129,699

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EPA:OSE had revenue of EUR 83.44 million and earned 46.03 million in profits. Earnings per share was 2.01.

Revenue	83.44M
Gross Profit	83.44M
Operating Income	53.84M
Pretax Income	49.44M
Net Income	46.03M
EBITDA	52.96M
EBIT	53.84M
Earnings Per Share (EPS)	2.01

Full Income Statement

Balance Sheet

The company has 75.75 million in cash and 43.89 million in debt, giving a net cash position of 31.86 million or 1.46 per share.

Cash & Cash Equivalents	75.75M
Total Debt	43.89M
Net Cash	31.86M
Net Cash Per Share	1.46
Equity (Book Value)	81.45M
Book Value Per Share	3.74
Working Capital	68.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 58.36 million and capital expenditures -34,000, giving a free cash flow of 58.32 million.

Operating Cash Flow	58.36M
Capital Expenditures	-34,000
Free Cash Flow	58.32M
FCF Per Share	2.67

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 64.52% and 55.17%.

Gross Margin	100.00%
Operating Margin	64.52%
Pretax Margin	59.25%
Profit Margin	55.17%
EBITDA Margin	63.46%
EBIT Margin	64.52%
FCF Margin	69.90%

Dividends & Yields

EPA:OSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.97%
Shareholder Yield	-22.97%
Earnings Yield	29.31%
FCF Yield	37.14%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EPA:OSE has an Altman Z-Score of 3.94.

Altman Z-Score	3.94
Piotroski F-Score	n/a